vs
agilon health, inc.（AGL）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是RANGE RESOURCES CORP的2.0倍（$1.6B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs -12.0%，领先34.8%），RANGE RESOURCES CORP同比增速更快（18.0% vs 3.1%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
AGL vs RRC — 直观对比
营收规模更大
AGL
是对方的2.0倍
$786.9M
营收增速更快
RRC
高出14.9%
3.1%
净利率更高
RRC
高出34.8%
-12.0%
两年增速更快
RRC
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $786.9M |
| 净利润 | $-188.9M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | -12.3% | — |
| 净利率 | -12.0% | 22.8% |
| 营收同比 | 3.1% | 18.0% |
| 净利润同比 | -78.5% | 88.8% |
| 每股收益（稀释后） | — | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRRC
| Q4 25 | $1.6B | $786.9M | ||
| Q3 25 | $1.4B | $655.3M | ||
| Q2 25 | $1.4B | $699.6M | ||
| Q1 25 | $1.5B | $846.3M | ||
| Q4 24 | $1.5B | $667.0M | ||
| Q3 24 | $1.5B | $567.9M | ||
| Q2 24 | $1.5B | $513.2M | ||
| Q1 24 | $1.6B | $598.8M |
净利润AGLRRC
| Q4 25 | $-188.9M | $179.1M | ||
| Q3 25 | $-110.2M | $144.3M | ||
| Q2 25 | $-104.4M | $237.6M | ||
| Q1 25 | $12.1M | $97.1M | ||
| Q4 24 | $-105.8M | $94.8M | ||
| Q3 24 | $-117.6M | $50.7M | ||
| Q2 24 | $-30.7M | $28.7M | ||
| Q1 24 | $-6.1M | $92.1M |
毛利率AGLRRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率AGLRRC
| Q4 25 | -12.3% | — | ||
| Q3 25 | -9.1% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -1.4% | — | ||
| Q4 24 | -7.1% | — | ||
| Q3 24 | -9.2% | — | ||
| Q2 24 | -2.9% | — | ||
| Q1 24 | -0.4% | — |
净利率AGLRRC
| Q4 25 | -12.0% | 22.8% | ||
| Q3 25 | -7.7% | 22.0% | ||
| Q2 25 | -7.5% | 34.0% | ||
| Q1 25 | 0.8% | 11.5% | ||
| Q4 24 | -6.9% | 14.2% | ||
| Q3 24 | -8.1% | 8.9% | ||
| Q2 24 | -2.1% | 5.6% | ||
| Q1 24 | -0.4% | 15.4% |
每股收益（稀释后）AGLRRC
| Q4 25 | — | $0.75 | ||
| Q3 25 | — | $0.60 | ||
| Q2 25 | — | $0.99 | ||
| Q1 25 | — | $0.40 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $204.0K |
| 总债务越低越好 | $35.0M | $1.2B |
| 股东权益账面价值 | $126.7M | $4.3B |
| 总资产 | $1.3B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资AGLRRC
| Q4 25 | $173.7M | $204.0K | ||
| Q3 25 | $171.7M | $175.0K | ||
| Q2 25 | $171.4M | $134.0K | ||
| Q1 25 | $136.9M | $344.6M | ||
| Q4 24 | $188.2M | $304.5M | ||
| Q3 24 | $148.2M | $277.4M | ||
| Q2 24 | $109.5M | $251.1M | ||
| Q1 24 | $111.7M | $343.1M |
总债务AGLRRC
| Q4 25 | $35.0M | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益AGLRRC
| Q4 25 | $126.7M | $4.3B | ||
| Q3 25 | $306.1M | $4.2B | ||
| Q2 25 | $408.9M | $4.1B | ||
| Q1 25 | $500.3M | $3.9B | ||
| Q4 24 | $471.0M | $3.9B | ||
| Q3 24 | $574.9M | $3.9B | ||
| Q2 24 | $676.6M | $3.9B | ||
| Q1 24 | $689.3M | $3.8B |
总资产AGLRRC
| Q4 25 | $1.3B | $7.4B | ||
| Q3 25 | $1.6B | $7.2B | ||
| Q2 25 | $1.7B | $7.1B | ||
| Q1 25 | $1.9B | $7.4B | ||
| Q4 24 | $1.7B | $7.3B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.2B | $7.3B | ||
| Q1 24 | $2.3B | $7.4B |
负债/权益比AGLRRC
| Q4 25 | 0.28× | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | — |
| 自由现金流率自由现金流/营收 | -1.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | — |
8季度趋势，按日历期对齐
经营现金流AGLRRC
| Q4 25 | $-20.5M | $257.5M | ||
| Q3 25 | $-18.2M | $247.5M | ||
| Q2 25 | $-35.1M | $336.2M | ||
| Q1 25 | $-32.0M | $330.1M | ||
| Q4 24 | $16.4M | $217.9M | ||
| Q3 24 | $-7.7M | $245.9M | ||
| Q2 24 | $-18.7M | $148.8M | ||
| Q1 24 | $-47.8M | $331.9M |
自由现金流AGLRRC
| Q4 25 | $-23.5M | — | ||
| Q3 25 | $-21.3M | — | ||
| Q2 25 | $-38.3M | — | ||
| Q1 25 | $-35.8M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $-11.2M | — | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-50.9M | — |
自由现金流率AGLRRC
| Q4 25 | -1.5% | — | ||
| Q3 25 | -1.5% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | -1.5% | — | ||
| Q1 24 | -3.2% | — |
资本支出强度AGLRRC
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率AGLRRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | -2.64× | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | — | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
